03/17/2021
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT
| |
03/16/2021
7:46 PM | Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:46 PM | Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:45 PM | Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:44 PM | MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:43 PM | Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:42 PM | Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:41 PM | Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:40 PM | Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2021
7:39 PM | BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/16/2021
7:38 PM | Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2021
4:31 PM | Regulus Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2021
10:05 AM | Regulus Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
| Form SC 13G
| |
02/17/2021
4:23 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
4:23 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
4:01 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
4:00 PM | Drygin Denis (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2021
3:19 PM | Regulus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/28/2021
3:03 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2021
7:32 PM | BALTIMORE DAVID (Reporting)
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
7:24 PM | Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/27/2021
7:16 PM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4/A
| |
01/12/2021
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT
| |
12/31/2020
3:03 PM | Regulus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/09/2020
4:13 PM | Point72 Asset Management, L.P. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G
| |
12/07/2020
4:14 PM | Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:13 PM | Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:12 PM | Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:12 PM | MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:11 PM | Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:10 PM | Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:10 PM | Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:09 PM | Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:08 PM | BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
4:06 PM | Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:22 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
3:21 PM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2020
3:18 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2020
7:40 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2020
3:10 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
3:09 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2020
3:43 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
3:32 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
5:08 AM | Regulus Therapeutics (Filer)
| Form 424B5
| |
08/31/2020
3:00 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2020
7:22 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
7:21 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:30 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2020
3:45 PM | Regulus Therapeutics (Issuer)
Witz Pascale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:44 PM | Regulus Therapeutics (Issuer)
Simeonidis Simos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:43 PM | Regulus Therapeutics (Issuer)
Rosen Hugh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:42 PM | RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:40 PM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:39 PM | Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:38 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2020
3:37 PM | BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
12:49 PM | Regulus Therapeutics (Filer)
| Form CT ORDER
| |
05/18/2020
3:28 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
3:27 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:36 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2020
7:03 PM | Regulus Therapeutics (Issuer)
Sarissa Capital Offshore Master Fund LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:01 PM | Regulus Therapeutics (Issuer)
Sarissa Capital Master Fund II LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2020
5:12 AM | Regulus Therapeutics (Filer)
| Form DEFA14A
| |
04/29/2020
5:09 AM | Regulus Therapeutics (Filer)
| Form DEF 14A
| |
03/27/2020
3:05 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2020
3:55 PM | Regulus Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2020
3:54 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
5:09 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
5:08 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
4:19 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A
| |
02/14/2020
12:51 PM | Altium Capital Management LP (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A
| |
02/10/2020
7:07 AM | Regulus Therapeutics (Subject)
Sanofi (Filed by)
| Form SC 13G/A
| |
01/29/2020
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT
| |
01/24/2020
3:13 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:12 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:11 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2020
8:01 PM | Regulus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/22/2020
4:27 PM | Regulus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/03/2020
8:53 PM | DENNER ALEXANDER J (Reporting)
Regulus Therapeutics (Issuer)
Sarissa Capital Catapult Fund LLC (Reporting)
Sarissa Capital Hawkeye Fund LP (Reporting)
Sarissa Capital Management LP (Reporting)
Sarissa Capital Offshore Master Fund LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
3:46 PM | EcoR1 Capital, LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G
| |
01/02/2020
8:59 PM | Regulus Therapeutics (Subject)
Sarissa Capital Management LP (Filed by)
| Form SC 13D/A
| |
12/31/2019
2:37 PM | Altium Capital Management LP (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A
| |
12/26/2019
4:03 PM | Regulus Therapeutics (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:02 PM | Regulus Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:02 PM | Regulus Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:01 PM | MOTT DAVID M (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:01 PM | MAKOWER JOSHUA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:00 PM | Makhzoumi Mohamad (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:00 PM | Florence Anthony A. Jr. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:59 PM | Chang Carmen (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:59 PM | Behbahani Ali (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:58 PM | BASKETT FOREST (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:57 PM | BARRIS PETER J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:57 PM | Growth Equity Opportunities V, LLC (Reporting)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
7:56 AM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
7:54 AM | Regulus Therapeutics (Issuer)
Witz Pascale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
7:52 AM | RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
7:50 AM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
7:01 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2019
4:37 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
